Sophora installs ChromoCure's cancer detection systems

NewsGuard 100/100 Score

ChromoCure, Inc. (PINKSHEETS: KKUR) today announced its has executed a Joint Venture Agreement with Sophora Diagnostic Lab, Inc., a profitable New York based cancer pathology lab ("Sophora").

Under the Terms, Sophora will join ChromoCure's pathology lab network and utilize ChromoCure's cancer detection systems as part of its diagnostic operations.

Sophora will market its enhanced diagnostic services to area labs. ChromoCure and Sophora will divide revenues derived from the system equally.

Sophora is ChromoCure's first and flagship installation for its cancer detection system, continuing designs and therapeutic technologies.

Installation, training, and system activation is anticipated to begin immediately. Additional installations of the Company's technology are planned as part of ChromoCure's lab network revenue and growth plan.

Source:

ChromoCure, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer